← Back to patent-cliff list
CAS 174483-06-8
ethyl 2-(4-(1-hydroxy-4-(4-(hydroxydiphenylmethyl)piperidin-1-yl)butyl)phenyl)-2-methylpropanoate
Codes: FEXO-014
Application context (from source-drug indications)
Allergic rhinitisFexofenadine HydrochlorideDermatitisFexofenadine HydrochloridePruritusFexofenadine HydrochlorideEczemaFexofenadine HydrochlorideAtopic dermatitisFexofenadine HydrochlorideSeasonal allergic rhinitisFexofenadine Hydrochloride
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Fexofenadine Hydrochloride | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
methanol→ethyl 2-(4-formylphenyl)-2-methylpropanoate→(2-(1,3-dioxolan-2-yl)ethyl)magnesium bromide→ethyl 2-(4-(3-(1,3-dioxolan-2-yl)-1-hydroxypropyl)phenyl)-2-methylpropanoate→ethyl 2-(4-(5-hydroxytetrahydrofuran-2-yl)phenyl)-2-methylpropanoate→ethyl 2-(4-(1-hydroxy-4-(4-(hydroxydiphenylmethyl)piperidin-1-yl)butyl)phenyl)-2-methylpropanoate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.